These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30352895)

  • 1. A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy.
    Grubb AL; McDonald TJ; Rutters F; Donnelly LA; Hattersley AT; Oram RA; Palmer CNA; van der Heijden AA; Carr F; Elders PJM; Weedon MN; Slieker RC; 't Hart LM; Pearson ER; Shields BM; Jones AG
    Diabetes Care; 2019 Feb; 42(2):208-214. PubMed ID: 30352895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults.
    Oram RA; Patel K; Hill A; Shields B; McDonald TJ; Jones A; Hattersley AT; Weedon MN
    Diabetes Care; 2016 Mar; 39(3):337-44. PubMed ID: 26577414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to N-terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes.
    Pöllänen PM; Härkönen T; Ilonen J; Toppari J; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e935-e946. PubMed ID: 34747488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
    Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
    Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
    Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
    Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
    Katulanda P; Shine B; Katulanda GW; Silva A; Asfir EL; Sheriff R; Somasundaram N; Long AE; Bingley PJ; McCarthy MI; Clark A; Matthews DR
    Diabetologia; 2008 Aug; 51(8):1368-74. PubMed ID: 18528678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
    Calsolari MR; Rosário PW; Reis JS; Silva SC; Purisch S
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):315-21. PubMed ID: 18438542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients.
    Chuzho N; Kumar N; Mishra N; Tandon N; Kanga U; Kaur G; Singh P; Mishra G; Sharma S; Mehra NK
    J Diabetes Res; 2021; 2021():4012893. PubMed ID: 34988229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
    Maziarz M; Janer M; Roach JC; Hagopian W; Palmer JP; Deutsch K; Sanjeevi CB; Kockum I; Breslow N; Lernmark A; ;
    Genes Immun; 2010 Jul; 11(5):406-15. PubMed ID: 20445565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
    Martinka E; Rončáková M; Mišániková M; Davani A
    Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years.
    Lynam A; McDonald T; Hill A; Dennis J; Oram R; Pearson E; Weedon M; Hattersley A; Owen K; Shields B; Jones A
    BMJ Open; 2019 Sep; 9(9):e031586. PubMed ID: 31558459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
    Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Cuthbertson D; Yu L; Schatz DA; Orban T; Eisenbarth G;
    Diabetes Care; 2011 Nov; 34(11):2435-7. PubMed ID: 21911777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.